Prismic Pharmaceuticals Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$15.7M
Prismic Pharmaceuticals General Information
Description
Developer of novel prescription therapies designed to address pain and inflammation. The company's therapies use prescribed drugs and focus on the research and development of patent-protected products to address inflammation and oxidative stress associated with renal and mental health disorders, enabling customers to get treatment related to inflammation.
Contact Information
Website
www.prismicpharma.comCorporate Office
- 474 Grove Street
- Suite 740
- Worcester, MA 01605
- United States
Corporate Office
- 474 Grove Street
- Suite 740
- Worcester, MA 01605
- United States
Prismic Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 28-Jun-2019 | $15.7M | Completed | Generating Revenue | ||
| 2. Early Stage VC | 01-May-2017 | Completed | Generating Revenue | |||
| 1. Seed Round | 20-Feb-2013 | $1.2M | $1.2M | Completed | Generating Revenue |
Prismic Pharmaceuticals Comparisons
Industry
Financing
Details
Prismic Pharmaceuticals Competitors (34)
One of Prismic Pharmaceuticals’s 34 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xalud Therapeutics | Venture Capital-Backed | New York, NY | ||||
| Cerecin | Venture Capital-Backed | Singapore, Singapore | ||||
| SpineThera | Venture Capital-Backed | Plymouth, MN | ||||
| Neurona Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
| Minerva Neurosciences | Formerly VC-backed | Burlington, MA |
Prismic Pharmaceuticals Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MBX Capital | Venture Capital | Minority |
Prismic Pharmaceuticals Acquisitions (1)
Prismic Pharmaceuticals’s most recent deal was a Merger/Acquisition with Scarista. The deal was made on 07-Feb-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Scarista | 07-Feb-2012 | Merger/Acquisition | Pharmaceuticals |
Prismic Pharmaceuticals FAQs
-
When was Prismic Pharmaceuticals founded?
Prismic Pharmaceuticals was founded in 2011.
-
Where is Prismic Pharmaceuticals headquartered?
Prismic Pharmaceuticals is headquartered in Worcester, MA.
-
What industry is Prismic Pharmaceuticals in?
Prismic Pharmaceuticals’s primary industry is Biotechnology.
-
Is Prismic Pharmaceuticals a private or public company?
Prismic Pharmaceuticals is a Private company.
-
What is the current valuation of Prismic Pharmaceuticals?
The current valuation of Prismic Pharmaceuticals is .
-
What is Prismic Pharmaceuticals’s current revenue?
The current revenue for Prismic Pharmaceuticals is .
-
How much funding has Prismic Pharmaceuticals raised over time?
Prismic Pharmaceuticals has raised $1.2M.
-
Who are Prismic Pharmaceuticals’s investors?
MBX Capital has invested in Prismic Pharmaceuticals.
-
Who are Prismic Pharmaceuticals’s competitors?
Xalud Therapeutics, Cerecin, SpineThera, Neurona Therapeutics, and Minerva Neurosciences are some of the 34 competitors of Prismic Pharmaceuticals.
-
When was Prismic Pharmaceuticals acquired?
Prismic Pharmaceuticals was acquired on 28-Jun-2019.
-
Who acquired Prismic Pharmaceuticals?
Prismic Pharmaceuticals was acquired by Quantum BioPharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
